期刊文献+

Ⅲ期上皮性卵巢癌复发的相关因素分析 被引量:7

Clinical Analysis of Stage Ⅲ Recurrent Ovarian Epithelial Cancer
暂未订购
导出
摘要 目的探讨影响Ⅲ期上皮性卵巢癌复发的相关因素。方法选取Ⅲ期上皮性卵巢癌85例,其中复发组31例,未复发组54例。测定并比较2组患者的纤维蛋白原(FIB)含量、部分凝血酶原时间(PT)、凝血酶时间(TT)、活化部分凝血酶原时间(APTT)、血小板计数(PLT)、血清癌抗原125(CA125)、术中腹水量、腹水肿瘤细胞学性质、FIGO分期、组织学类型及组织学分级、残留灶大小、术中盆腔或(和)腹主动脉淋巴结是否切除及术后2个月CA125下降情况。Logistic回归分析影响复发的相关因素。结果复发组术前PT、TT缩短,腹水肿瘤细胞学阳性率、≥2cm残留癌灶所占比例、未行淋巴结切除术及术后2个月CA125未降至正常所占比例与未复发组比较差异有统计学意义(P<0.05或P<0.01),多因素Logistic回归分析显示残留肿瘤≥2cm、腹水肿瘤细胞学阳性、术中未行淋巴结切除及术后2个月CA125未正常是复发的独立危险因素。结论残留灶大小、腹水肿瘤细胞学性质、淋巴结是否切除及术后2个月血清CA125水平可以作为预测Ⅲ期卵巢上皮性癌复发的重要参考因素。 Objective To discuss possible causes of stageⅢ recurrent ovarian epithelial cancer. Methods A total of 85 ovarian epithelial cancer patients (stage Ⅲ) were allocated to recurrent group (n=31) and non-recurrent group (n=54). The levels of plasma fibrinogen (FIB), plasma prothrombin time (PT), thrombin time (TT) and activated partial thromboplastin time (APTI) were detected by automatic coagulation analyzer in patients with ovarian epithelial cancer. The blood platelet (PLT) was measured by Sysmex KX-21. The electrochemiluminescence method was used to measure the serum cancer antigen 125 (CA125). The amount of ascites, cytology of ascites tumors, FIGO substages, histological type and grade, size of residual tumor during operation, pelvic or abdominal lymph node resectable or not, and CA125 level 2 months after operation were analyzed. The related factors of recurrence were analyzed. Results Results of univariate analysis showed that levels of PT and Tr were significantly shorter before operation in recurrent group. There were significant differences in the positive rate of ascites cytology, the rate of ≥2 cm residual tumor, the rate of unresected lymph node and the abnormal rate of CA125 2 months after operation between patients with recurrence and patients without recurrence (P 〈 0.05 or P 〈 0.01). Results of multivariate analysis showed that ≥2 cm residual tumor,the positive rate of ascites cytology, the rate of unresected lymph node and abnormal rate of CA125 2 months after operation were important risk factors for recurrence in patients with ovarian epithelial cancer. Conclusion In patients with ovarian epithelial cancer of stagelll ,residual tumor, cytology of ascites tumors, lymph node resected or not and CA125 level 2 months after operation were important prognostic factors of recurrence.
作者 周立香 张虹
出处 《天津医药》 CAS 北大核心 2013年第1期41-43,共3页 Tianjin Medical Journal
关键词 卵巢肿瘤 CA-125抗原 腹水 复发 淋巴结切除术 LOGISTIC模型 ovarian neoplasm carcinoma CA-125 antigen ascites recurrence lymph node resection Logistic models
  • 相关文献

参考文献9

  • 1沈铿,郎景和,孔北华,等.卵巢恶性肿瘤[M].见:曹泽毅.妇科常见肿瘤诊治指南.第3版.北京:人民卫生出版社,2010: 86.
  • 2王长青,肖强.组织因子研究的新进展[J].中外医疗,2008,27(9):77-78. 被引量:1
  • 3Yokota IV,Koizume S,Miyagi E,et al. Self-production of tissuefactor-coagulation factor VI complex by ovarian cancer cells[J]. BrJ Cancer, 2009, 101(12):2023-2029.
  • 4方峻,魏文宁,夏凌辉,宋善俊.组织因子/活化因子Ⅶ复合物影响人卵巢癌细胞侵袭及转移能力的研究[J].中华血液学杂志,2004,25(9):523-527. 被引量:9
  • 5Tang MK, Zhou HY, Yam JW, et al. c-Met overexpression con-tributes to the acquired apoptotic resistance of non-adherent ovari-an cancer cells through a cross talk mediated by phosphatidylinos-itol 3-kinase and extracellular signal-regulated kinase 1/2[J]. Neo-plasia, 2010,12(2): 128-138.
  • 6Balbi G, Manganaro MA, Monteverde A, et al. Ovarian cancer:lymph node metastasis [J]. Eur J Gynaecol Oncol, 2009, 30(3):289-291.
  • 7Hacker NF, Valmadre S, Robertson G. Management of retroperi-toneal lymph nodes in advanced ovarian cancer [J]. Int J GynecolCancer, 2008, 18(1): 7-10.
  • 8Gardner GJ, Baser RE, Brady MF, et al. CAI25 regression in ovari-an cancer patients treated with intravenous versus intraperitonealplatinum-based chemotherapy: a gynecologic oncology group study[J]. Gynecol Oncol, 2012, 124(2):216-220.
  • 9Mackay HJ, Brady MF, Oza AM, et al. Prognostic relevance of un-common ovarian histology in woman with stage M/IV epithelial o-varian cancer[J]. Int J Gynecol Cancer, 2010, 20(6): 945-952.

二级参考文献23

  • 1方峻,魏文宁,夏凌辉,宋善俊.组织因子/活化因子Ⅶ复合物影响人卵巢癌细胞侵袭及转移能力的研究[J].中华血液学杂志,2004,25(9):523-527. 被引量:9
  • 2[1]Camerer E,Huang W,Coughlin SR.Tissue factor-and factor X-dependent activation of protease-activated receptor-2 by factor Ⅶa[J].Proc Natl Acad Sci USA,2000,97:5255~5260.
  • 3[2]Hjortoe GM,Petersen LC,Albrektsen T,et al.Tissue factor-factor Ⅶa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results ha increased cell migration[J].Blood,2004,103:3029~3O37.
  • 4[3]Pendurthi UR,Allen KE,Ezban M,et at.Factor Ⅶa and thrombin induce the expression of Cyr61 and connective tissue growth factor,extracellular matrix signaling proteins that could act as possible downstream mediators in factor Ⅶ.tissue factor-induced signal transduction[J].J Biol Chem,2000,275:14632~14641.
  • 5[4]Riewald M,Ruf W.Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor[J].Proc Natl Acad Sci USA.2001,98:7742-7747.
  • 6[5]Ahamed J,Ruf W.Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain[J].J Biol Chem,2004,279:23038~23044.
  • 7[6]Versteeg HH,Peppelenbosch MP,Spek CA.The pleiotropic effects of tissue factor:a possible role for factor Ⅶa-induced intracellular signalling[J].Thromb Haemost,2001,86:1353~1359.
  • 8[7]Zhang Y,Deng Y,Luther T,et al.Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice[J].J Clin Invest,1994,94:1320~1327.
  • 9[8]Yamahata H,Takeshima H,Kuratsu J,et al.The role of thrombin in the neo-vascularization of malignant gliomas:an intrinsic modulator for the upregulation of vascular endothelial growth factor[J].Int J Oncol 2002,20:921~928
  • 10[9]sterud B,Flmgstad T.Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection:related to an unfavourable prognosis[J].Thromb Haemost 1983,49:5,7.

共引文献9

同被引文献56

引证文献7

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部